GGHC
MIRO

Gilder Gagnon Howe & Co’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-160,000
Closed -$1.86M – 443
2021
Q2 		$1.86M Buy
+160,000
New +$2.06M 0.01% 306

Other funds holding MIRO

GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Gilder Gagnon Howe & Co's MIRO Position: Q3 2021 in Review

Gilder Gagnon Howe & Co sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q3 2021, closing a stake of 160,000 shares — an estimated $1.86M sold.

Gilder Gagnon Howe & Co first reported a position in MIRO in Q2 2021 and held it in 1 quarter. The position peaked at $1.86M in Q2 2021. 19 funds tracked by Wall St. Rank hold MIRO as of Q3 2021.

  • Gilder Gagnon Howe & Co reported no remaining Miromatrix Medical Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 160,000 Miromatrix Medical Inc. Common Stock shares in Q3 2021, an estimated $1.86M.
  • Gilder Gagnon Howe & Co first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's Miromatrix Medical Inc. Common Stock position peaked at $1.86M in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q3 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2021, filed 15 Nov 2021.